Incidence and risk factors for 30-day readmission in ulcerative colitis: nationwide analysis in biologic era

Background and study aim Ulcerative colitis (UC) is a chronic relapsing and remitting disease requiring frequent hospitalization. Biologics have become the recommended initial therapy for Biologics in patients with moderate to severe UC. Our aim was to estimate the changes in Nationwide Healthcare utilization and assess predictive factors of 30-day readmission, morbidity and mortality of UC. Methods This is a retrospective observational study...